Domain Associates — 2015 Investments
7 investments dated 2015 · listed companies and verified rows first · show all
Aldeyra develops medicines for immune-mediated diseases, with product candidates aimed at inhibiting inflammatory cells linked to ocular and systemic conditions.
BiotechMedical DevicesLexington, US
Todd C. Brady(Executive Officer, Director)Stephen Tulipano(Executive Officer)Scott L. Young(Executive Officer)
BoardJesse I. Treu(Director)inBen Bronstein(Director)Gary Phillips(Director)
Board seatJesse Treu· per SEC Form D · $18.4M raise · filed Jan 2015
BiotechSan Mateo, US
Anthony Ford(Executive Officer)Michael Kitt(Executive Officer)Kathleen Sereda Glaub(Executive Officer, Director)
BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)
Board seatJesse Treu· per SEC Form D · $55M raise · filed Jul 2015
Co-investorsPappas CapitalThird Rock Ventures
BiotechDurham, US
Bernice Kuca(Executive Officer)Mathers P. Thomas(Executive Officer, Director)Nadia Rupniak(Executive Officer)Timothy C. Gupton(Executive Officer)
BoardJesse I. Treu(Director)inRichard J. Markham(Director)
Board seatJesse Treu· per SEC Form D · $37.1M raise · filed Jan 2015
Co-investorsPappas CapitalTVM Capital
BiotechBellevue, US
Michael Gertner(Executive Officer, Director)
BoardLouis Cannon(Director)Christopher Shen(Director)Immanuel Thangaraj(Director)Henry A. Plain, Jr.(Director)
Board seatBrian Halak· per SEC Form D · $22.4M raise · filed Sep 2015
Co-investorsLightstone Ventures
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases.
BiotechHealthtechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Michael Narachi(Executive Officer, Director)Thomas Cannell(Executive Officer)
BoardBrian H. Dovey(Director)in
Board seatBrian DoveyEckard Weber· per SEC Form D · $90M raise · filed Sep 2015
Co-investorsCross Creek AdvisorsNew Enterprise Associates (NEA)Sofinnova VenturesDomain Partners
HealthtechDuluth, US
Anthony V. Lando(Executive Officer, Director)Todd Meyer(Executive Officer)Dilip Paithanker(Executive Officer)Robert Leslie(Executive Officer)Todd Brady(Director)Dilip Paithankar(Executive Officer)
Board seatJesse Treu· per SEC Form D · $15M raise · filed Sep 2019
BiotechCarlsbad, US
Thomas M. Estok(Executive Officer, Director)Tracy Parrott(Executive Officer)Dennis Bilski(Executive Officer)
BoardEvgeny Zaytsev, M.D.(Director)Alain Schreiber(Director)
Board seatKim KamdarEckard Weber· per SEC Form D · $1.2M raise · filed Jul 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.